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Abstract
Aims/hypothesis Previous studies on isolated islets have
demonstrated tight coupling between calcium (Ca2+) influx
and oxygen consumption rate (OCR) that is correlated with
insulin secretion rate (ISR). To explain these observations,
we have proposed a mechanism whereby the activation of a
highly energetic process (Ca2+/metabolic coupling process
[CMCP]) by Ca2+ mediates the stimulation of ISR. The aim
of the study was to test whether impairment of the CMCP
could play a role in the development of type 2 diabetes.
Methods Glucose- and Ca2+-mediated changes in OCR and
ISR in isolated islets were compared with the time course of
changes of plasma insulin concentrations observed during
the progression to hyperglycaemia in a rat model of type-2
diabetes (the University of California at Davis type 2 dia-
betes mellitus [UCD-T2DM] rat). Islets were isolated from
UCD-T2DM rats before, 1 week, and 3 weeks after the
onset of hyperglycaemia.
Results Glucose stimulation of cytosolic Ca2+ and OCR was
similar for islets harvested before and 1 week after the onset
of hyperglycaemia. In contrast, a loss of decrement in islet
OCR and ISR in response to Ca2+ channel blockade coin-
cided with decreased fasting plasma insulin concentrations
observed in rats 3 weeks after the onset of hyperglycaemia.
Conclusions/interpretation These results suggest that phe-
notypic impairment of diabetic islets in the UCD-T2DM rat
is downstream of Ca2+ influx and involves unregulated
stimulation of the CMCP. The continuously elevated levels
of CMCP induced by chronic hyperglycaemia in these islets
may mediate the loss of islet function.
Keywords Calcium . Hyperglycaemia . Insulin secretion .
Islets . Oxygen consumption
Abbreviations
CMCP Ca2+/metabolic coupling process
FCCP Carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone
ER Endoplasmic reticulum
ISR Insulin secretion rate
OCR Oxygen consumption rate
UCD-T2DM University of California at Davis type 2
diabetes mellitus
Introduction
An essential step triggering insulin secretion by pancreatic
beta cells is closure of KATP channels leading to the opening
of voltage-dependent Ca2+ channels [1]. Increased
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metabolic rate generates another essential signal, without
which increased Ca2+ influx does not stimulate ISR [2, 3].
A number of factors generated by increased metabolism
have been proposed including NADPH [4], fatty-acid sig-
nalling [5], ATP/ADP ratio [6], cytochrome c [7], mitochon-
drial GTP [8], reactive oxygen species [9] and factors
associated with pyruvate carboxylase and anaplerosis
[10–12]. How beta cells integrate both Ca2+ and metabolic
factors is not understood, but we have hypothesised the
existence of a cascade of steps that are dually regulated by
these two factors and govern the triggering of insulin secre-
tion [13]. We have named this process, linking the Ca2+
signal with insulin secretion, the ‘Ca2+/metabolic coupling
process (CMCP)’ and have sought to characterise its defin-
ing features by quantifying metabolic and electrophysiolog-
ical variables of isolated islets [13, 14]. The major identifier
of the CMCP is its use of approximately 35% of glucose-
stimulated energy production, which cannot be accounted
for by the energy used in exocytosis of secretory granules
[15]. The CMCP can be quantified by the decrement of
glucose-stimulated oxygen consumption rate (OCR) in re-
sponse to blocking the influx of Ca2+, a variable reflecting
the work associated with Ca2+-activated processes [15]. The
link between OCR and ATP usage is supported by studies
demonstrating that the majority of ATP is generated by
mitochondrial respiration [16]. Importantly, the OCR linked
to the CMCP is highly correlated with substrate-stimulated
insulin secretion rate (ISR) [15], and its activation is essen-
tial for sustained insulin secretion to occur [13]. Like ISR, it
is under dual control by both Ca2+ entering the cell via L-
type Ca2+ channels [14] and metabolic rate [13]. Finally the
process is upstream of potentiation of glucose-stimulated
ISR by protein kinases whereby ISR is increased without
significantly altering OCR [14, 15]. These observations lead
us to hypothesise that the combination of Ca2+ influx and
metabolic rate leads to the activation of a highly energetic
process (CMCP) that couples Ca2+ to its effect on ISR [13].
To further establish the validity of this hypothesis, we
tested whether impairment of the CMCP could play a role in
the progression of type 2 diabetes. The approach taken
involved measurements on islets isolated from diabetic rats
at different stages in the development of hyperglycaemia
and decreased insulin secretion. The diabetic rat model used
(University of California at Davis type 2 diabetes mellitus
[UCD-T2DM]) was generated by crossing obese insulin-
resistant Sprague–Dawley rats with ZDF-lean rats, which
have a defect in beta cell function [17]. The progression of
glycaemic control in the model was characterised by eugly-
caemia in the young rats, followed by steadily increasing
circulating glucose levels accompanied by increased ISR.
After onset of hyperglycaemia, by 3 weeks ISR declined and
by 3 months a large fraction of the beta cells were destroyed.
Previous studies carried out on islets from these rats
indicated that loss of secretory function did not correlate
with loss of islet volume or number [17]. Therefore, we
concluded that impaired islet secretory function was likely
to underlie the decreased plasma insulin concentrations ob-
served concomitant with increasing glucose levels, and that
the UCD-T2DM rat was an appropriate animal model with
which to investigate the longitudinal role of the CMCP in
islet function.
The aim of the study, therefore, was to investigate the
intracellular mechanisms responsible for the impaired secre-
tory function that develops between 1 and 3 weeks after
onset of hyperglycaemia. Isolated islets underwent analysis
of multiple variables reflecting sequential components in the
stimulus–secretion coupling pathway. Thus, glucose stimu-
lation of metabolism was assessed by increases in OCR,
opening of voltage-dependent Ca2+ channels was assessed
by cytosolic Ca2+ and activation of the CMCP was assessed
by the decrement in OCR in response to blocking Ca2+
influx. These variables were compared longitudinally with
plasma insulin concentrations measured in vivo to deter-
mine which step(s) were associated with the decline of islet
secretory function. Based on standard analysis of islet met-
abolic and Ca2+ response, the islets appeared functionally
intact. However, our results showed that dysregulation of
the CMCP occurring downstream of Ca2+ entry is associated
with markedly reduced ISR and plasma insulin concentra-
tions during the transition to hyperglycaemia/overt diabetes.
Methods
Chemicals KRB supplemented with 20 mmol/l HEPES/
NaHEPES (Roche, Indianapolis, IN, USA) and 0.1% bovine
serum albumin (Serological Corporation, Norcross, GA,
USA) was used for perifusion experiments and was made
as previously described [15].
Animals Male UCD-T2DM rats were housed in the animal
facility in the Department of Nutrition at the University of
California, Davis and maintained on a 14:10-h light–dark
cycle. Rats characterised as hyperglycaemic or diabetic
(blood glucose >11.1 mmol/l for 2 consecutive days [17]),
were studied either 1 week or 3 weeks after onset. Blood
glucose was determined on 5 μl of whole blood using a
OneTouch Glucometer (Lifescan, Milpitas, CA, USA).
Male Sprague–Dawley rats (used as controls) were pur-
chased from Harlan (Livermore, CA, USA). The experimen-
tal protocols were approved by the Institutional Animal Care
and Use Committees of the Universities of Washington and
California, Davis.
Rat islet isolation and culture Islets were harvested by
collagenase digestion of the pancreas and purified as
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previously described [18, 19]. Rats were anaesthetised by
intraperitoneal injection of sodium pentobarbital (35 mg/
230 g rat). Before the experiments islets were cultured for
18 h at 37°C in RPMI Medium 1640 containing 10% fetal
bovine serum (Invitrogen, Carlsbad, CA, USA).
Measurement of OCR, cytochrome c reduction and ISR A
perifusion system was used that concomitantly measured
OCR and cytochrome c reduction while collecting outflow
fractions for subsequent determination of ISR [18, 20, 21].
Islets (125–175) were loaded into in each of two perifusion
chambers. OCR was calculated as flow rate (30–40 μl/min)
multiplied by the difference between inflow and outflow
oxygen tension measured by detecting the phosphorescence
lifetime (MFPF-100; Tau Theta, Boulder, CO, USA) of an
oxygen-sensitive dye painted on the inside of the perifusion
chamber [15]. Absorption by cytochrome c was measured
by light transmitted at 550 nm through the bed of islets/
Cytodex beads [18]. Insulin was measured by ELISA (Mer-
codia, Uppsala, Sweden) or RIA (Millipore Corporation,
Billerica, MA, USA).
Automated histological determination of beta cell area For-
malin-fixed, paraffin-embedded pancreas sections (5 μm)
were stained with anti-insulin antibody (1:2,000; Sigma-
Aldrich, St Louis, MO, USA) followed by biotinylated goat
anti-mouse IgG (1:500; Jackson ImmunoResearch, West
Grove, PA, USA), Vector ‘Elite’ ABC-HP (Burlingame,
CA, USA), 3,3′-diaminobenzidine substrate and haematox-
ylin counterstain and then mounted on coverslips. Whole
slide images were generated using a Nanozoomer Digital
Pathology slide scanner (Olympus America, Center Valley,
PA, USA). The insulin-positive area was computed based on
pixel colour and density for each section using Visiopharm
software (Hoersholm, Denmark) and verified by manual
examination of segmented images. Total (100%) section
area (149±8 mm2, mean±SEM) was assessed, and total
pancreas area was determined as the sum of insulin-
negative and insulin-positive pancreas areas.
Insulin content Insulin content per islet was determined in
wells of 24-well plates (in triplicate) containing five islets in
0.2 ml of culture media, after adding 1 ml of a hydrochloric
acid/95% ethanol mixture (2% vol./vol.) and incubating for
60 min. After centrifugation at 800g for 5 min, the super-
natant fraction was transferred to fresh tubes, and insulin
was measured by ELISA (Mercodia). For some experi-
ments, islet insulin content was measured immediately fol-
lowing their isolation, and no differences were seen relative
to islets cultured overnight (data not shown).
Imaging and quantification of cytosolic Ca2+ Cytosolic Ca2+
was measured by fluorescence imaging after islets were
incubated in 2 μmol/l Fura-2 AM (Invitrogen) and 0.02%
pluronic acid for 40 min at 37°C and perifused in KRB
(containing 5 mmol/l NaHCO3) as previously described
[22]. Results are displayed as the ratio of the fluorescent
intensity during excitation at either 340 or 380 nm (F340/
F380).
Plasma glucose and insulin measurements Blood samples
were collected after an overnight (12 h) fast from the tails of
male UCD-T2DM rats (n=7 per group). Non-fasting blood
glucose concentrations were measured before fasting (at
14:00–16:00 hours) using a glucometer. Plasma was assayed
for glucose and insulin concentrations using an enzymatic
colorimetric assay (Thermo DMA, Louisville, CO, USA)
and ELISA (Millipore, St Charles, MO, USA), respectively.
Perifusion protocols and data analysis The basic protocol
for the OCR, ISR and Ca2+ perifusion experiments entailed
a 90-min baseline period at 3 mmol/l glucose followed by
stimulation with 20 mmol/l glucose for 60 min and subse-
quent inhibition of Ca2+ influx with 5 μmol/l nimodipine for
60 min. OCR data are displayed as the change relative to the
baseline calculated as the average of values obtained be-
tween −10 and 0 min. To assess mitochondrial uncoupling
in islets, the protocol entailed the inhibition of the F0F1ATPase
with oligomycin to remove the coupled portion of OCR
[23, 24], followed by the addition of a mitochondrial
uncoupler (FCCP). Steady-state values were calculated
as the average of the final 10 min of each experimental
condition. Statistical significance (p values) was gener-
ated from the calculation of ANOVA with a post hoc
Bonferonni test using Kaleidagraph (Synergy Software,
Reading, PA, USA), except for the immunohistochemi-
cal data upon which a Student’s t test using Microsoft
Excel (Redmond, WA, USA) was performed.
Results
Animal characteristics Islets from three groups of UCD-
T2DM rats were compared: euglycaemic, and 1 or 3 weeks
after the diagnosis of hyperglycaemia (fed blood glucose
concentrations >11.1 mmol/l for two consecutive measure-
ments). Age, weight and blood glucose levels were recorded
for all rats just before islet harvest (Table 1). The ages and
weights of the three groups of UCD-T2DM rats were sim-
ilar. Blood glucose concentrations were approximately two-
fold higher in the rats 1 week after onset of hyperglycaemia
relative to euglycaemic rats (p<0.001) and further increased
to approximately threefold higher in the rats 3 weeks post
onset (p<0.001). Control data were obtained from islets
isolated from Sprague–Dawley rats, which were slightly
younger and lighter than the UCD-T2DM rats. A second
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cohort of male UCD-T2DM rats were used to characterise
circulating glucose and insulin concentrations at times
corresponding to the times that the islet measurements were
made. Non-fasting blood glucose was significantly elevated
in UCD-T2DM rats 1 and 3 weeks after onset of hyper-
glycaemia (Fig. 1). Insulin was elevated 1 week following
onset but decreased by 3 weeks despite the continued
hyperglycaemia.
Assessment of the CMCP in control islets To determine
whether disruption of the CMCP was associated with the
loss of regulated insulin secretion occurring 1–3 weeks fol-
lowing onset of hyperglycaemia, we first measured varia-
bles reflecting the operation of the CMCP in islets harvested
from control Sprague–Dawley rats. As expected, all three
measurements increased robustly in response to increased
glucose concentrations (Fig. 2). The subsequent blockade
of Ca2+ influx by L-type Ca2+ channels (with 5 μmol/l nimo-
dipine) decreased steady-state OCR by 0.16±0.03 (about
Table 1 Characteristics of UCD-T2DM and control rats
Characteristic Control UCD-T2DM
Pre-onset 1 week post-onset 3 weeks post-onset
Number of rats 5 8 8 8
Age (weeks) 8.0±0.1 10.9±0.2 10.7±0.5 11.7±0.1
Weight (g) 402±4 440±13 440±34 444±12
Blood glucose (mmol/l) 7.6±0.5 6.8±0.5 12.2±2.1*** 18.9±2.0***
Values are average±SEM
Age, weight and blood glucose were recorded immediately before harvesting the islets. UCD-T2DM rats used in the study were either
normoglycaemic or had become hyperglycaemic 1 or 3 weeks before harvesting their islets for assessment. Sprague–Dawley rats were used as a
source of control islets
***p<0.001 generated from an ANOVA on the UCD-T2DM rats with a post hoc Bonferonni test carried out using Kaleidagraph (Synergy
Software). The two values with asterisks were found to be statistically different from the pre-onset values
Fig. 1 Circulating glucose and insulin concentrations at 2 weeks be-
fore, and 1 and 3 weeks after, the onset of diabetes in the UCD-T2DM
rat. Non-fasting blood glucose (black circle), fasting plasma glucose
(white circle) and fasting plasma insulin concentrations (triangle) were
plotted as a function of time before and after onset of hyperglycaemia.
Values are mean±SEM. *p<0.05 by Student’s t test compared with
value at 2 weeks before onset
3 mmol/l 
l 
l 
l 
l 
l 
glucose 20 mmol/l glucose
20 mmol/l glucose
5 µmol/l nimodipine
Fig. 2 Effect of blocking Ca2+-influx through L-type Ca2+ channels on
OCR, Ca2+ and ISR by islets isolated from normoglycaemic Sprague–
Dawley rats that were stimulated with 20 mmol/l glucose. Islets were
perifused in the presence of 3 mmol/l glucose for 90 min then
20 mmol/l for 60 min, followed by the addition of 5 μmol/l nimodipine.
OCR and ISR were measured concomitantly using the flow culture
system (n=5). Detection of cytosolic Ca2+ by fluorescence imaging
was measured in separate experiments (n=3). Data are means±SEM
and are displayed as the change in signal relative to the steady-state
value obtained at 3 mmol/l glucose. Steady-state values of OCR and
ISR at 3 mmol/l glucose are listed in Table 2. Statistical analysis was
carried out by comparing steady-state values before and after each
change in media composition using a paired t test
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one third of that stimulated by 20 mmol/l glucose)
reflecting the energy used by the CMCP; ISR was
completely abolished demonstrating the tight coupling
between Ca2+ influx, ATP usage and insulin secretion.
The Ca2+ response to glucose was biphasic; due to the
slower flow rates required when measuring OCR and
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glucose 20 mmol/l glucose
20 mmol/l glucose
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Fig. 3 Effect of blocking Ca2+-influx through L-type Ca2+ channels on
glucose-stimulated islets from UCD-T2DM rats isolated before (a),
and 1 week (b) and 3 weeks (c) after, the onset of hyperglycaemia.
Islets were perifused using identical protocols to those described in
Fig. 2 except Ca2+ was not measured for (b). Data are displayed and
were analysed as described in Fig. 2 legend, except that n=8 for OCR
and ISR measurements, and n=4 for Ca2+ measurements
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ISR, first phase insulin secretory response to glucose
was not observed.
Loss of Ca2+-sensitive OCR and ISR in islets occurred in
UCD-T2DM rats 3 weeks after onset of hyperglycaemia To
determine which component of stimulus-secretion coupling
was correlated with decreased plasma insulin concentrations
in UCD-T2DM rats, we repeated the measurements pre-
sented in Fig. 2 using isolated islets harvested before, and
1 and 3 weeks after, onset of hyperglycaemia. Islets har-
vested from UCD-T2DM rats before the onset of hyper-
glycaemia had normal responses in OCR to glucose, but
only ~50% of the Ca2+ and ISR response seen in the islets
from control rats (Fig. 3a, Table 2). The OCR responses to
nimodipine were qualitatively similar, but the changes were
smaller than that for control islets (decrement of OCR as a
percentage of the glucose-stimulated increase was 22 vs
34% for the pre-onset and control islets, respectively
[Table 2]). Likewise for islets harvested from UCD-T2DM
rats 1 week after onset of hyperglycaemia, the two variables
reflecting operation of the CMCP, the decrement in OCR
and ISR in response to nimodipine (Fig. 3b), were similar to
those observed in islets harvested before onset. Notably,
glucose-stimulated ISR by islets harvested from rats 1 week
after onset of hyperglycaemia was increased by 65% com-
pared with islets harvested from rats before the onset. Islets
harvested 3 weeks after onset of hyperglycaemia exhibited
decreased glucose-stimulated ISR, but normal Ca2+ re-
sponse and only slightly reduced ΔOCR in response to
20 mmol/l glucose relative to pre-onset islets (Fig. 3c),
indicating that the loss of ISR was not due to the inability
of islets to respond to increased metabolism by closure of
KATP channels. In contrast, Ca
2+-sensitive OCR was nearly
completely abolished, and ISR was only partially inhibited
by inhibition of Ca2+ influx (Fig. 3c), suggesting that the
coupling between Ca2+ influx, energy consumption and ISR
was lost.
Correlation of islet characteristics with longitudinal
changes in plasma insulin and glucose levels in UCD-
T2DM rats The steady-state values of measured variables
in islets shown in Figs 2 and 3 were tabulated and compared
with the longitudinal changes of fasting plasma insulin
concentrations in UCD-T2DM rats (Table 2). During the
progression from euglycaemia to hyperglycaemia, the
responses of ISR measured in vitro mirrored the changes
of fasting plasma insulin seen in vivo, while glucose stim-
ulation of OCR and cytosolic Ca2+ in islets remained un-
changed. Notably, the disappearance of the Ca2+-sensitive
OCR coincided with the marked decline of plasma insulin
concentrations that occurred 3 weeks after the onset of
hyperglycaemia.
Table 2 Steady-state values of OCR, ISR and ΔCa2+ calculated from kinetic responses by islets harvested from rats at different stages of glycaemic
control
Characteristic Control UCD-T2DM
Pre-onset 1 week post-onset 3 weeks post-onset
Fasting insulin ND 433±33 500±42 217±17
OCR3 mmol/l glc 0.39±0.09 1.4±0.4 1.1±0.2 0.9±0.3
ΔOCR20 mmol/l glc 0.48±0.07 0.47±0.06 0.47±0.05 0.41±0.07
% Decrement OCRnim 33±2 22±3 16±3 3±3***
ISR3 mmol/l glc 0.05±0.02 0.1±0.06 0.19±0.03 0.15±0.05
ISR20 mmol/l glc 1.5±0.2 1.1±0.3 1.9±0.1 0.8±0.2***
% Decrement ISRnim 96±1 83±5 88±1 44±7***
ΔCa2+20 mmol/l glc 0.18±0.02 0.12±0.02 ND 0.11±0.01
Data are the average±SEM
Steady-state calculations were made on data from individual experiments (the composites of which are shown in Figs 2, 3, and the number of
replicates performed are listed in the figure legends). The changes in OCR and Ca2+ (ΔOCR and ΔCa2+ ) were calculated as the difference in
steady-state values at 20 mmol/l glucose minus the values at 3 mmol/l glucose. OCR response of Ca2+ channel blockade by nimodipine was
represented as the per cent decrement relative to the ΔOCR in response to glucose. The per cent decrement in ISR in response to nimodipine was
calculated relative to the actual steady-state ISR observed in the presence of 20 mmol/l glucose. Units are pmol/l for insulin, pmol min−1 (100
islets)−1 for ISR and nmol min−1 (100 islets)−1 for OCR; the ratiometric Ca2+ measurement was unitless. Fasting blood insulin was not measured
for the rats used as a source of islets in this study, but was measured for a separate group of rats ranging from 8 to 11 weeks old (fasting plasma
insulin concentrations were 187±14 pmol/l (n=14) and 189±22 pmol/l (n=14), respectively)
***p<0.001 generated from an ANOVAwith a post hoc Bonferonni test carried out using Kaleidagraph (Synergy Software). The three values with
asterisks were found to be statistically different from both pre- and 1 week-onset values, except for glucose-stimulated ISR whose values from islets
that were pre-onset and islets that were harvested 3 weeks after the onset of hyperglycaemia were similar
glc, glucose; nim, nimodipine
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Contribution of mitochondrial uncoupling to Ca2+-sensitive
OCR in UCD-T2DM rat islets The extent of uncoupling in
islets has been assessed by inhibition of the F0F1-ATPase; this
stops the dissipation of the proton gradient across the mito-
chondrial membrane that is supported by electron transport
chain activity but not that due to uncoupled proton leak [25,
26]. Accordingly, islets were perifused as in Fig. 2, but instead
of blocking Ca2+ channels, the F0F1ATPase was inhibited by
oligomycin, followed by the mitochondrial uncoupler carbon-
yl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP). In
control islets glucose-stimulated OCR decreased in response
to oligomycin by 82±1.4% (Fig. 4a) and was increased by the
uncoupling agent FCCP, suggesting that mitochondria in nor-
mal glucose-stimulated islets are largely coupled. However,
simultaneous measurement of cytochrome c reduction indi-
cated that some of the OCR decrease may have been due to
inhibition of metabolic pathways by the two agents, as cyto-
chrome c reduction dropped in parallel with the OCR. Irre-
spective of the possible error associated with using metabolic
poisons, OCR decrements due to oligomycin were similar in
islets from both euglycaemic and 3-week hyperglycaemic
UCD-T2DM rats (Fig. 4b) to those observed with control rat
islets, indicating that changes in the uncoupling state of
3 mmol/l 
glucose
20 mmol/l 
glucose
20 mmol/l glc
5 µmol/l oligo
20 mmol/l glc
+ oligo/FCCP
a
***
***
***
***
***
***
+ anti
A + KCN
20 mmol/l 
glucose
20 mmol/l glucose
5 µmol/l oligomycin
20 mmol/l glucose
+ oligo/FCCP
b
l
l
l
Fig. 4 Assessment of uncoupling in islets from UCD-T2DM rats. (a)
Islets were perifused in the presence of 3 mmol/l glucose for 90 min.
The glucose in the perifusate was subsequently raised to 20 mmol/l for
45 min, followed by the addition of a blocker of the F0F1ATPase
(5 μmol/l oligomycin) and subsequent addition of a mitochondrial
uncoupler (1 μmol/l FCCP). OCR and cytochrome c reduction were
measured concomitantly using the flow culture system. OCR data is
displayed as the change in signal relative to the steady-state value
obtained at 3 mmol/l glucose (determined by averaging data obtained
in the final 10 min before the increase in glucose). Steady-state OCR at
3 mmol/l glucose was 0.20±0.06 nmol min−1 (100 islets)−1 (n=6).
Cytochrome c data were normalised to values obtained in the presence
of a blocker of electron flow into cytochrome c (antimycin A) and of
electron transfer from cytochrome c (KCN) as 0% and 100%
respectively, as done previously [18]. The cytochrome c data were
inherently more inaccurate than OCR, and data smoothing was carried
out by calculating moving averages over 6-min intervals. Therefore,
the kinetics of the cytochrome c data are delayed relative to the OCR
data, although the algorithm did not affect the steady-state values that
were reached. Data were plotted as mean±SEM. ***p<0.001, com-
paring steady-state values before and after each change in buffer
composition (paired t test). (b) Using the same protocol as in (a), islets
harvested from pre-onset (lower curve) and 3 weeks post-onset rats
were assessed (n=4). To facilitate comparison, data was normalised to
the average value attained during the final 5 min of the high-glucose
period. To maintain clarity, error bars (representing the SEM) are only
shown in a single direction for each curve. No statistical difference
between the two curves was detected
***
l
l
l
l
l
Fig. 5 Insulin content of isolated islets harvested from control rats and
UCD-T2DM rats before, and 1 and 3 weeks after, becoming hypergly-
caemic. Data are means±SEM, n=3 or 4. ***p<0.001 (Student’s t test)
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mitochondria are not likely to mediate changes in Ca2+-sensi-
tive OCR that occurred during this period.
Insulin content, islet yield and beta cell area during transi-
tion to hypoinsulinaemia Islets from UCD-T2DM rats ini-
tially contained insulin stores that were similar to those of
the islets from control rats, and then decreased precipitously
between 1 and 3 weeks following the onset of hyperglycae-
mia (Fig. 5). Despite this change in insulin content, secre-
tion was still 70% of that by islets from euglycaemic
UCD-T2DM rats (Table 2), suggesting that insulin content
had not become limiting. The yield of islets harvested
from UCD-T2DM rats was low at all stages compared
with the yield from control rats (130±8 vs 418±17 islets/rat).
However, due to the increase in size of islets from UCD-
T2DM rats, the total islet volume harvested (calculated by
estimating the size of the islet diameter and assuming each
islet was spherical) was similar in the two rat strains (7.3±0.5
vs 5.9±0.2 μl).
To determine whether beta cell loss contributed to im-
paired ISR, the insulin-positive area relative to total
a b c d
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f
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Fig. 6 Quantification of islet area from pancreas harvested from rats
before, and 2 weeks and 10 weeks after, onset of hyperglycaemia. (a–
d) Representative images from pancreas sections stained for insulin
(brown staining) showing islets from Sprague–Dawley controls (a) and
UCD-T2DM rats before the onset of diabetes (b), with recent-onset
diabetes (2 weeks after hyperglycaemia) (c) or with long-term diabetes
(greater than 10 weeks after onset of hyperglycaemia) (d). The images
show the increased damage to islet morphology as diabetes progressed.
(e, f). Representative example of output from Visiopharm software
where (e) is a stained pancreatic section and (f) is the computer-
generated identification of insulin-positive (green) or insulin-negative
(pancreas; blue) areas. (g). Beta cell area expressed as total insulin-
positive area / total pancreas area assessed. Number of replicates were
4, 5, 7 and 8, for control, pre-onset, 2 weeks post-onset and 10 weeks
post-onset of hyperglycaemia, respectively. **p<0.01 (ANOVA),
where insulin-positive area for islets harvested 10 weeks post-onset
was significantly different from insulin-positive area for both 2 weeks
post-onset and pre-onset islets
OCR
Insulin
secretion
CMCP
Metabolic 
rate
Ca2+
Glucose
Chronic hyperglycaemia
+ -
Time-dependent
loss of effect
Fig. 7 Schematic depiction of the normal coupling between Ca2+,
OCR and ISR, and the observed effects seen in the UCD-T2DM rat
model. In normal islets, ISR is controlled by Ca2+ influx through L-
type Ca2+ channels, and a factor generated when metabolic rate is
increased, via a highly energetic process we have termed the CMCP.
Sustained ISR only occurs when the CMCP is activated by both Ca2+
and increased metabolic rate. During the transition from hyper- to
hypo-insulinaemia occurring between 1 and 3 weeks after onset of
hyperglycaemia in the UCD-T2DM rat, islet function is characterised
by continually activated CMCP (i.e. not inhibited by Ca2+ channel
blockade) and a time-dependent decrease in coupling between CMCP
and insulin secretion. We speculate that the continuous operation of the
CMCP is energetically unfavourable to islet function and survival
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pancreatic area was quantified in pancreas sections. Clear
fragmentation and damage to the UCD-T2DM rat islets was
evident even before the onset of hyperglycaemia (Fig. 6a–d).
However, beta cell area, quantified by an automated imaging
system (as illustrated in Fig. 6e, f), tended to be higher in
euglycaemic UCD-T2DM rats relative to control rats
(p=0.12), consistent with the higher OCR at low glucose,
and was not decreased in 1-week-onset rats relative to pre-
onset UCD-T2DM rats (Fig. 6g). Beta cell area in islets from
rats with hyperglycaemia longer than 10 weeks, though, was
significantly decreased (Fig. 6g). These data do not support
beta cell loss as a primary mediator of the loss of insulin
secretory function that occurs early in the course of hyper-
glycaemia in UCD-T2DM rats.
Discussion
Impaired coupling between Ca2+ and OCR was associated
with diminished insulin secretory function in vivo Based on
previously obtained data from in vitro experiments showing
a tight correlation between the CMCP (as reflected by Ca2+-
sensitive OCR) and ISR [13–15], we hypothesised that loss
of CMCP regulation during the progression of the diabetes
in the UCD-T2DM model would coincide with the decrease
in plasma insulin concentrations during the progression of
hyperglycaemia seen in vivo [17]. Glucose-stimulated OCR
and Ca2+ did not change significantly in islets harvested
following the onset of hyperglycaemia, and glucose stimu-
lation of ISR was still operational in the diabetic islets.
Therefore glucose sensing and steps generating an increased
energy state leading to closing of KATP channels and Ca
2+
influx, the standard focus of islet functional analysis, were
intact. Our approach to evaluating islet function centred on
responses to blocking glucose-stimulated Ca2+ influx, which
in normal islets leads to a reproducible decrease in OCR and
complete cessation of insulin secretion [14, 15]. The main
finding of this study was the demonstration that loss of
Ca2+-sensitivity of OCR and ISR coincided with the de-
creased plasma insulin levels seen in UCD-T2DM rats.
The results are consistent with a link between dysregulation
of steps downstream of Ca2+ influx (those comprising the
CMCP) and the loss of glucose-stimulated ISR observed
after prolonged hyperglycaemia.
The phenotypic mechanism of insulin release in the UCD-
T2DM diabetic islet A goal of the study was to obtain in vitro
data that would generate a candidate mechanism to explain the
decline in plasma insulin levels occurring after exposure to
chronic hyperglycaemia. Our initial interpretation of the lack
of change in OCR of diabetic islets in response to Ca2+
channel blockade was that the CMCP was no longer function-
al. However, OCR, Ca2+ and ISR were still robustly
stimulated by glucose and, furthermore, insulin secretion
was still observable in the presence of Ca2+ channel blockade,
indicating that the CMCP was still operational. In islets from
control rats, blocking Ca2+ influx by L-type Ca2+ channels
abolishes sustained insulin secretion by all known physiolog-
ical secretagogues including glucose, fatty acids [27] and
amino acids [28], as well as potentiators of nutrient-
stimulated ISR including acetylcholine and GLP-1 [13]. Thus,
the continued secretion of insulin in the presence of nimodi-
pine observed in islets 3 weeks after the onset of hypergly-
caemia was unexpected, as was the ability to secrete insulin in
response to glucose by islets that do not decrease OCR in
response to blocking Ca2+ influx. The most likely explanation
for these observations is that the CMCP in diabetic islets
remains constitutively activated, which would result in the
observed lack of OCR response to nimodipine, thus allowing
glucose to stimulate ISR in the presence of nimodipine. This
explanation was further supported by results showing that
glucose-stimulated OCR was not diminished in these islets.
The decrease in insulin levels seen in vivo, in the face of
continuously activated CMCP, suggests that the chronically
stimulated CMCP does not favour the maintenance of appro-
priately regulated ISR by the islet (represented schematically
in Fig. 7). How this happens is still under investigation, since
at this point we have not shown a causal relation between
overstimulation of CMCP and decreased ISR. Future work
will involve assessing islets from UCD-T2DM rats that are
treated with insulin and DPP-4 inhibitors.
Contribution to the impairment of insulin secretion made by
changes in mass vs function Although it is clear that islets
from rats 3 weeks post-onset of hyperglycaemia are func-
tionally impaired, we also considered the potential contri-
butions of loss of insulin content or beta cell area. Although
beta cell mass in the UCD-T2DM rat ultimately declines with
long-term hyperglycaemia [17], neither islet yield nor beta cell
area were decreased during the transition to hypoinsulinaemia
(1–3 weeks). Islet insulin content fell dramatically during the
transition from hyper- to hypo-secretion of insulin seen in
vivo [17]. It seems likely that this was a factor in the impaired
secretory function observed in vivo, but the continued robust
response of ISR in response to glucose in vitro suggests that
content of insulin had not reached levels low enough to
become strongly rate limiting. The loss of insulin content
could be mediated by the increased energy demands of con-
tinuous operation of the CMCP, as suggested by studies where
diazoxide, a blocker of the CMCP [15], prevents loss of
insulin content in hyperglycaemia [29].
Consistent with increases in beta cell mass typically
observed in obese rodents [30, 31], many islets isolated
from the UCD-T2DM rats at all stages of glycaemia studied
were hyperplastic and over 300 μm in diameter. As would
be expected from islets with greater numbers of beta cells,
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the overall OCR per islet was much larger (two- to fourfold
greater than that observed in normal-sized islets). Since the
increased beta cell area was less than twofold that of con-
trols, it follows that the elevated basal OCR might be in part
due to greater numbers of non-beta cells. However, the
changes in ISR and OCR stimulated by glucose were similar
to those seen in the islets from control rats. In addition, since
the larger islets harvested from euglycaemic UCD-T2DM
rats behaved qualitatively similarly to the control islets, our
data does not suggest that hyperplasia of the islets is in itself
a factor governing the impairment of function in vivo [32].
Neither does increased uncoupling of mitochondria appear
to play a role in mediating the transition between normally
functioning islets and a lack of Ca2+-sensitivity of the OCR.
Thus the loss of secretion in vivo is most strongly associated
with changes in the coupling between Ca2+, OCR and ISR,
and perhaps changes of insulin biosynthesis, but not with
changes in mass or size of the islet population.
Alternative mechanisms mediating loss of Ca2+-sensitive
OCR and ISR Based on the nearly identical cytosolic Ca2+
responses to glucose, and equal contribution by L-type Ca2+
channels to this response, by pre- and post-diabetic islets,
we favour the conclusion that the loss of Ca2+-sensitive
OCR and ISR was due to steps downstream of Ca2+ signal-
ling. However, the method of measurement that we used for
determining cytosolic Ca2+ cannot resolve gradients of Ca2+
within the cell, particularly in microdomains surrounding
the secretory granules. Therefore it cannot be ruled out that
even if the overall flux into the cell through L-type Ca2+
channels was not impaired during the transition to hypoin-
sulinaemia, Ca2+ may preferentially accumulate in sites
away from processes controlling OCR and ISR during the
progression of diabetes. In this case, a low CMCP response
would be achieved due to lack of stimulation by L-type Ca2+
channels. In such a scenario, Ca2+ from other channels could
support the continued secretion of insulin in the face of
greatly diminished L-type Ca2+ channel activity.
Relationship between the phenotype of diabetic islets and
subsequent beta cell destruction Although islet mass
remains relatively stable up until 2 months post-onset of
hyperglycaemia, previous studies have demonstrated
marked disruption of islet structure 3 months after the onset
of diabetes [17]. Whether continuous activation of the
CMCP is detrimental to islet viability or proliferation was
not determined in the present study, although this possibility
is supported by studies showing a link between Ca2+, endo-
plasmic reticulum (ER) stress and beta cell death [33, 34].
Consistent with the notion that continued overstimulation of
Ca2+-activated processes in the beta cell is harmful, it has
been shown that diazoxide reduces islet apoptosis and ER
stress in the face of exposure to palmitate [35] and
stimulation of KATP channel activity protects murine pan-
creatic beta cells against oxidative stress induced by H2O2 or
sulfonylureas [36]. Therefore our findings provide a novel
demonstration that constitutive activation of Ca2+-stimulated
energy usage precedes the destruction of islets in the UCD-
T2DM rat and is associated with loss of islet function.
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